...
首页> 外文期刊>Tetrahedron >Synthesis of an hexadentate tricyclic tetraazadiacetic ligand as precursor for MRI contrast enhancement agents
【24h】

Synthesis of an hexadentate tricyclic tetraazadiacetic ligand as precursor for MRI contrast enhancement agents

机译:六齿三环四氮二乙酸配体的合成作为MRI造影剂的前体

获取原文
获取原文并翻译 | 示例
           

摘要

A tricyclic tetraazadiacetic compound, which is a rigidified derivative of cyclo-PCTA12 ligand with an oxo-ethylene bridge replacing an ethylene one, was prepared. The synthetic route involved the macrocyclization between an activated amido-disulfonamide and the 2,6-bis(bromomethyl)pyridine. The acetate side chains were grafted on the macrocyclic backbone to lead to the highly rigid tricyclic ligand in 34% overall yield in four steps from the linear amido-disulfonamide precursor. The corresponding Gd(III) and Mn(II) complexes were then prepared in order to evaluate their potential as contrast agent for MRI.
机译:制备了三环四氮杂二乙酸化合物,其是环-PCTA12配体的刚性衍生物,具有取代乙烯的氧代-乙烯桥。合成途径涉及活化的酰胺基-二磺酰胺和2,6-双(溴甲基)吡啶之间的大环化。乙酸酯侧链接枝在大环骨架上,以四个步骤从线性酰胺基-二磺酰胺前体以34%的总收率得到高度刚性的三环配体。然后制备相应的Gd(III)和Mn(II)配合物,以评估其作为MRI造影剂的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号